Alexa

FDA to Review “Free Speech” for Off-Label Drug Marketing

Off-Label Drug Marketing Argues “Free Speech,” FDA to Review Drug Safety Guidelines Off-label drug marketing has created huge controversies with major pharmaceutical manufacturers, leading to pharmaceutical lawsuits against drugs like migraine drug Topamax, or antipsychotic Risperdal. Doctors and patients who prescribed or used drugs for off-label … [Read more...]

BestLawyers.comAVBetter Business Bureau